These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 566590)

  • 21. Arylpyrrolidines as narcotic antagonists.
    McCarthy DA
    Adv Biochem Psychopharmacol; 1973; 8(0):145-55. PubMed ID: 4211813
    [No Abstract]   [Full Text] [Related]  

  • 22. Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats.
    Korányi L; Endröczi E
    Acta Physiol Hung; 1983; 62(1):75-83. PubMed ID: 6650196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potential for dependence of analgesics and psychopharmaceuticals].
    Hoffmeister F
    Arzneimittelforschung; 1984; 34(9A):1096-107. PubMed ID: 6541933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The withdrawal syndrome and lipid peroxidation during the chronic administration of narcotic analgesics to rats].
    Konstantinopol'skiĭ MA; Pirozhkov SV; Solov'eva AG; Panchenko LF; Barkov NK
    Eksp Klin Farmakol; 1992; 55(1):21-4. PubMed ID: 1363943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The potential antinarcotic effects of guanfacine].
    Marusov IV; Bogdanov EG; Marusova IB
    Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.
    Maynert EW
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():89-95. PubMed ID: 5749391
    [No Abstract]   [Full Text] [Related]  

  • 28. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
    Martin WR; Gorodetzky CW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in self-stimulation response during chronic morphine treatment and after withdrawal of morphine in rats.
    Kamei C
    Jpn J Pharmacol; 1994 Sep; 66(1):163-5. PubMed ID: 7861664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of brain acetylcholine release by morphine and its antagonists in normal and morphine-dependent rats.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1974 Jan; 50(1):57-62. PubMed ID: 4856723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in fixed-interval behavior during chronic morphine treatment and morphine abstinence in rats.
    Babbini M; Gaiardi M; Bartoletti M
    Psychopharmacologia; 1976 Feb; 45(3):255-9. PubMed ID: 943119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nalorphine on the in vitro morphine metabolism and on the p-nitrophenol conjugation in rat liver.
    Tampier L; Sanchez E; Mardones J
    Arch Int Pharmacodyn Ther; 1970 Dec; 188(2):290-7. PubMed ID: 5523475
    [No Abstract]   [Full Text] [Related]  

  • 33. Lowered seizure threshold as a part of the narcotic abstinence syndrome in rats.
    Adler MW; Lin C; Smith KP; Tresky R; Gildenberg PL
    Psychopharmacologia; 1974 Feb; 35(3):243-7. PubMed ID: 4857278
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction between morphine and reinforcing lateral hypothalamic stimulation.
    Ornstein K; Huston JP
    Psychopharmacology (Berl); 1977 Nov; 54(3):227-35. PubMed ID: 413137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the hypothalamo-neurohypo-physical neuro-secretory materials of rats during different phases of morphine administration.
    Ray AK; Ghosh JJ
    J Neurochem; 1969 Jan; 16(1):1-5. PubMed ID: 5813349
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of cessation of injections in the increased oxygen assimilation of rat skeletal muscle during morphine withdrawal.
    Billiar RB; Harvey SC
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):368-72. PubMed ID: 4797374
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of compound 48/80 on the precipitated withdrawal syndrome of dogs.
    Akcasu A; Bouffard-Eyüboğlu H
    Agents Actions; 1984 Jan; 14(1):49-53. PubMed ID: 6538377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of alcohol withdrawal symptoms by nalorphine in chronic alcoholic patients.
    Markley HG; Mezey E
    Int J Addict; 1978 Apr; 13(3):395-402. PubMed ID: 669863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nalorphine-induced abstinence syndrome in morphine-tolerant albino rats.
    KAYMAKCALAN S; WOODS LA
    J Pharmacol Exp Ther; 1956 May; 117(1):112-6. PubMed ID: 13320309
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychoactive compounds and their antibodies: effect on self-stimulation of the lateral hypothalamus in morphinized rats.
    Epstein OI; Vorob'eva TM; Geiko VV; Berchenko OG
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():132-3. PubMed ID: 12949678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.